Edwards Lifesciences Corp (EW)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 819,300 | 930,100 | 645,000 | 369,900 | 501,400 |
| Marketable Securities | 98,900 | 341,000 | 555,300 | 690,300 | 450,400 |
| Receivables | 510,200 | 414,600 | 454,200 | 425,800 | 388,500 |
| Inventories | 431,400 | 396,600 | 401,000 | 367,600 | 356,600 |
| Other current assets | 105,600 | 111,800 | 66,100 | 81,500 | 73,600 |
| TOTAL | $2,018,400 | $2,240,000 | $2,171,400 | $1,985,100 | $1,819,300 |
| Non-Current Assets | |||||
| PPE Net | 588,800 | 580,000 | 543,700 | 516,200 | 497,300 |
| Investments And Advances | 519,000 | 532,100 | 467,500 | 391,700 | 369,200 |
| Intangibles | 1,347,300 | 830,900 | 837,000 | 838,100 | 834,600 |
| Other Non-Current Assets | 306,900 | 327,000 | 319,400 | 320,300 | 333,400 |
| TOTAL | $2,762,000 | $2,270,000 | $2,167,600 | $2,066,300 | $2,034,500 |
| Total Assets | $4,780,400 | $4,510,000 | $4,339,000 | $4,051,400 | $3,853,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 584,800 | 97,100 | 532,800 | 478,200 | 458,300 |
| Accrued Expenses | N/A | 435,400 | N/A | N/A | N/A |
| TOTAL | $584,800 | $532,500 | $532,800 | $478,200 | $458,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 847,900 | 822,300 | 600,600 | 602,500 | 602,200 |
| aiOther Non-Current Liabilities | 605,000 | 536,200 | 513,800 | 499,500 | 494,000 |
| TOTAL | $1,452,900 | $1,358,500 | $1,114,400 | $1,102,000 | $1,096,200 |
| Total Liabilities | $2,037,700 | $1,891,000 | $1,647,200 | $1,580,200 | $1,554,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 629,408 | 637,487 | 641,442 | 638,637 | 635,288 |
| Common Shares | 243,200 | 242,600 | 242,000 | 241,000 | 239,800 |
| Retained earnings | 4,145,800 | 3,906,300 | 3,747,800 | 3,606,400 | 3,479,800 |
| Other shareholders' equity | -181,900 | -198,700 | -171,100 | -178,400 | -172,700 |
| TOTAL | $2,742,700 | $2,619,000 | $2,691,800 | $2,471,200 | $2,299,300 |
| Total Liabilities And Equity | $4,780,400 | $4,510,000 | $4,339,000 | $4,051,400 | $3,853,800 |